United States President Donald Trump announced that his administration will soon impose a significant tariff on pharmaceutical products. Speaking at the National Republican Congressional Committee (NRCC) dinner, Trump stated that the measure is designed to bring pharmaceutical manufacturing back to the United States.

“We’re going to tariff our pharmaceuticals and once we do that, they’re going to come rushing back into our country, because we’re the big market,” Trump said. He emphasized that the U.S. remains a vital consumer base, which gives it leverage in reshaping global supply chains.

Trump expressed confidence that the tariffs would drive companies to relocate operations from China and other countries back to the U.S., leading to the reopening and construction of new plants across the nation. “They will leave China, they will leave other places, they’re going to be opening up their plants all over the place in our country,” he declared.

This move marks a continuation of Trump’s broader strategy of using tariffs to boost domestic industry and reduce reliance on foreign supply chains. It also aligns with his efforts to bolster American manufacturing and secure critical sectors like pharmaceuticals, especially in light of vulnerabilities highlighted during recent global events.

While specific details on the tariff rates and implementation timeline have not yet been disclosed, the announcement signals a strong policy direction aimed at reviving the U.S. pharmaceutical production sector. It remains to be seen how international pharmaceutical firms and trade partners will respond.

Trump’s remarks were met with applause from attendees at the NRCC event, reflecting support from within the Republican Party for measures that prioritize American production and economic independence. The administration is expected to release further details on the proposed tariffs in the coming days.